Institute for Molecular Virology

Phone612-624-1926
Email[email protected]
Websitehttps://www.virology.umn.edu/

Organization profile

The Institute for Molecular Virology (IMV) seeks to improve the health of the citizens of Minnesota through education, outreach, and research (basic, clinical, translational). The IMV unites virus researchers from across the University of Minnesota in a strategic manner to enhance the mission and goals of the IMV.

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

Hideki Aihara
- aihar001umnedu
- Chemical and Structural Biology (BMBB) - Professor
- Chemical and Structural Biology (TMED) - Leader
- Biochemistry, Molecular Biology, and Biophysics (TMED) - Associate Professor
- Institute for Molecular Virology
- Genetics Mechanisms of Cancer
Person: Member, Faculty, Medical School Affiliates
19962024
Matthew T Aliota
- mtaliotaumnedu
- Veterinary and Biomedical Sciences - Associate Professor
- Institute for Molecular Virology
- Host-Pathogen Interface Biology
Person: Faculty
20072024
Georgiy Aslanidi
- gaslanidumnedu
Person: Member, Faculty
19962024

93 Active
566 Finished

Component A: Longitudinal Surveillance of Congenital CMV Infections Identified by Newborn Screening
Schleiss, M. R. (PI), Baker-James, K. C. (CoI) & Jansen, R. J. (CoI)
CENTERS FOR DISEASE CONTROL & PREVENTION
9/30/23 → 9/29/27
Project: Research project
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
Blazar, B. R. (PI), Beebe, T. J. (CoI), Bellin, M. D. (CoI), Berge, J. M. (CoI), Billings, J. L. (CoI), Bischof, J. C. (CoI), Brearley, A. M. (CoI), Call, K. T. (CoI), Fu, S. S. (CoI), Fulkerson, J. (CoI), Guan, W. (CoI), Hardeman, R. R. (CoI), Haynes, D. A. (CoI), Henning-Smith, C. E. (CoI), Johnson, S. (CoI), Jones-Webb, R. J. (CoI), Kozhimannil, K. B. (CoI), Langworthy, B. (CoI), Lim, H. H. (CoI), Melton-Meaux, G. B. (CoI), Nunez, A. (CoI), Pakhomov, S. V. (CoI), Pieczkiewicz, D. S. (CoI), Randolph, A. C. (CoI), Riggs, S. (CoI), Rudser, K. (CoI), Schleiss, M. R. (CoI), Shen, S. (CoI), Vaughn, B. P. (CoI) & Vock, D. M. (CoI)
NIH NAT'L CTR FOR ADVANCING TRAN SCIENCE
9/18/23 → 7/31/30
Project: Research project
Microbial-induced maternal factors that influence fetal immune development
Schuldt, N. (PI), Bierle, C. J. (CoI), Hamilton Hart, S. E. (CoI) & Subramanian, S. (CoI)
NIH NAT'L INST OF CHILD HEALTH/HUMAN DEV
9/14/23 → 8/31/26
Project: Research project

Synthesis and evaluation of anti-Giardia activity of oseltamivir analogs
VanKoten, H. W., Pence, B. C., Klinkenberg, J. R., Das, S. & Patterson, S. E., Feb 1 2025, In: Bioorganic and Medicinal Chemistry Letters. 116, 130035.
Research output: Contribution to journal › Article › peer-review
A compact stem-loop DNA aptamer targets a uracil-binding pocket in the SARS-CoV-2 nucleocapsid RNA-binding domain
Esler, M. A., Belica, C. A., Rollie, J. A., Brown, W. L., Moghadasi, S. A., Shi, K., Harki, D. A., Harris, R. S. & Aihara, H., Nov 27 2024, In: Nucleic acids research. 52, 21, p. 13138-13151 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Harnessing the power of viroimmunotherapy to overcome challenges in cancer therapy
LaRocca, C. J. & Davydova, J., Jun 20 2024, In: Molecular Therapy Oncology. 32, 2, 200811.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access

What Do We Know About Holiday COVID Safety? Good Question
Hedberg, C. W., Rhame, F. S. & Ulrich, A. K.
11/18/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
Minnesota COVID-19 cases soaring as families make Thanksgiving plans
Schacker, T. W.
11/16/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
National fund started in Minnesota for families of health care workers who died of COVID
Osterholm, M. T.
11/16/20
1 item of Media coverage
Press/Media: Expert Comment or Interview